Cell phone app to support adolescents and young adults with cancer
Feasibility Study of the Implementation of a Cell Phone Application to Help Adolescents and Young Adults in Their Therapeutic and Educational Journey
This study is testing a new phone app designed to help young people aged 15 to 25 with cancer by providing support and information during their treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 60 (estimated) |
| Ages | 15 Years to 25 Years |
| Sex | All |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Trial ID | NCT05617131 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on developing and validating a digital application called OnKO-Tips & Tricks for adolescents and young adults aged 15 to 25 diagnosed with solid or liquid cancers. The application aims to provide tailored support during their therapeutic and educational journey, addressing both medical and psychosocial needs. Patients at the Strasbourg center will test the app over a six-month feasibility study, providing feedback on its practicality and benefits. The initiative is part of a broader effort to enhance care for this age group, which often experiences a transition between pediatric and adult healthcare systems.
Who should consider this trial
Good fit: Ideal candidates for this study are adolescents and young adults aged 15 to 25 who are currently diagnosed with solid or liquid cancers and are being treated at the Strasbourg center.
Not a fit: Patients who do not speak or write French fluently or those who are under legal protection may not benefit from this study.
Why it matters
Potential benefit: If successful, this application could significantly improve the support and resources available to young cancer patients, enhancing their treatment experience and overall well-being.
How similar studies have performed: While the use of digital health tools in oncology is growing, this specific application for adolescents and young adults is a novel approach that has not been extensively tested in similar contexts.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: * Subject whose age is ≥ 15 years and ≤ 25 years * Subject diagnosed at the Strasbourg center (HUS and ICANS) with solid or liquid cancer * Subject followed in the Strasbourg center (HUS and ICANS) * Subject (or his/her legal representatives) having given his/her (their) agreement to participate in the evaluation survey of the OnKO-TnT digital application * Subject agreeing to complete all satisfaction questionnaires * The subject understands, speaks and writes French fluently * Subject having a cell phone capable of downloading the application (developed for any type of cell phone) Criteria for non-inclusion : * Opposition of the subject (or the holders of parental authority) to participate in the satisfaction survey * Subject under legal protection * Subject under guardianship or curatorship
Where this trial is running
Strasbourg
- Service Pédiatrie Onco-hématologie - Pédiatrie III - CHU de Strasbourg - France — Strasbourg, France (Recruiting)
Study contacts
- Study coordinator: Natacha ENTZ-WERLE, MD, PhD
- Email: natacha.entz-werle@chru-strasbourg.fr
- Phone: 33 3 88 12 83 89
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.